Medivir AB MVIR
OMXSTO · Sweden · Health Technology
SEK 1.59-0.04 (-2.69%)
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Medivir AB (STU:MVR0) reports strong progress across its pipeline, with key data readouts expected in 2027 and a strengthened cash position to fund operations into 2030.
Medivir AB (FRA:MVR0) showcases significant pipeline progress and a robust financial position despite facing developmental challenges.
Medivir AB (STU:MVR0) reports steady revenue, improved operating loss, and strategic initiatives to bolster its pipeline and financial position.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.